José Miguel Escandell Planells-rekin lankidetzan egindako argitalpenak (5)

2010

  1. Inhibition of delayed-type hypersensitivity by cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of nuclear factor AT translocation to the nucleus

    Journal of Pharmacology and Experimental Therapeutics, Vol. 332, Núm. 2, pp. 352-363

2007

  1. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in Lewis rats by suppression of tumor necrosis factor-α in T lymphocytes and macrophages

    Journal of Pharmacology and Experimental Therapeutics, Vol. 320, Núm. 2, pp. 581-590

  2. Dihydrocucurbitacin B inhibits delayed type hypersensitivity reactions by suppressing lymphocyte proliferation

    Journal of Pharmacology and Experimental Therapeutics, Vol. 322, Núm. 3, pp. 1261-1268

  3. New insight into the inhibition of the inflammatory response to experimental delayed-type hypersensitivity reactions in mice by scropolioside A

    European Journal of Pharmacology, Vol. 555, Núm. 2-3, pp. 199-210

2006

  1. Dihydrocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis

    European Journal of Pharmacology, Vol. 532, Núm. 1-2, pp. 145-154